Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

169.45 -5.27 (-3.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 402,161
Open 171.32
Bid (Size) 163.20 (1)
Ask (Size) 174.46 (1)
Prev. Close 174.72
Today's Range 168.49 - 173.60
52wk Range 108.89 - 237.85
Shares Outstanding 55,056,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
From Masimo
Via Business Wire
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier. 
Via Investor's Business Daily

Performance

YTD
+16.04%
+16.04%
1 Month
+9.78%
+9.78%
3 Month
+34.35%
+34.35%
6 Month
+9.60%
+9.60%
1 Year
-23.50%
-23.50%

More News

Read More
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
Via Investor's Business Daily
Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery
From Masimo
Via Business Wire
The Latest Analyst Ratings for Masimo
Via Benzinga
Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch
From Masimo
Via Business Wire
How Masimo Is Taking On Electronics Giant Apple — And Winning
Via Investor's Business Daily
Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
Via Benzinga
ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent
From Masimo
Via Business Wire
Masimo's Return On Capital Employed Overview
Via Benzinga
Expert Ratings for Masimo
Via Benzinga
7 Analysts Have This to Say About Masimo
Via Benzinga
New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department
From Masimo
Via Business Wire
New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality
From Masimo
Via Business Wire
Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference
From Masimo
Via Business Wire
New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section
From Masimo
Via Business Wire
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Masimo Takes Major Step in Connecting the Hospital to the Home
From Masimo
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Via Benzinga
Masimo Hosts Investor Day to Detail Next Phase of Its Growth Trajectory
From Masimo Corporation
Via Business Wire
Masimo Announces Limited Market Release of Sepsis Index
From Masimo
Via Business Wire
Masimo Announces Full Market Release of Hydration Index for the Masimo W1™ Advanced Health Tracking Watch
From Masimo
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery
From Masimo
Via Business Wire
Masimo to Present in Piper Sandler 34th Annual Healthcare Conference
From Masimo
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.